Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06512740 · ClinicalTrials.gov registry record
The 2021-2022 Study of Family and Staff Well-Being in Head Start FACES Programs
A clinical trial, sponsored by Mathematica Policy Research.
- Completed
- Registry status
- 4,825
- Enrollment target
NCT06512740: Completed study, sponsored by Mathematica Policy Research.
NCT06512740 is a clinical trial that has completed, run by Mathematica Policy Research. The registered enrollment target is 4,825 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06512740 has completed, sponsored by Mathematica Policy Research.
- COMPLETED
- Registry status
- 4,825 participants
- Enrollment target
Study Summary
The 2021-2022 Study of Family and Staff Well-Being in Head Start Family and Child Experiences Survey (FACES) Programs (the 2021-2022 Study) builds on FACES 2019, a national study of children and families participating in Head Start programs. In the year following the start of the COVID-19 pandemic, there was a need to understand how children, families, and Head Start staff were faring. The 2021-2022 Study explores child, family, and staff well-being, primarily in the programs that participated in FACES 2019.
Primary Outcome
Indicators of physical well-being were assessed by parent report to a survey item on if child's health is excellent, very good, good, fair, or poor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,825 participants |
| Start Date | 2021-08-30 |
| Est. Completion | 2022-07-31 |
What the finished NCT06512740 record still lists
NCT06512740 is an observational study that tracks outcomes without assigning an intervention. Its 4,825 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT06512740 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06512740 about?
NCT06512740 is a clinical study titled "The 2021-2022 Study of Family and Staff Well-Being in Head Start FACES Programs". The 2021-2022 Study of Family and Staff Well-Being in Head Start Family and Child Experiences Survey (FACES) Programs (the 2021-2022 Study) builds on FACES 2019, a national study of children and families participating in Head Start programs. In the year following the start of the COVID-19 pandemic, ...
What is the current status of trial NCT06512740?
This trial is currently completed. The enrollment target is 4,825 participants. The study started on 2021-08-30. Estimated completion is 2022-07-31.
Who is sponsoring clinical trial NCT06512740?
This trial is sponsored by Mathematica Policy Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01719055 · 4,800 participants
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
- NCT05485675 · 4,800 participants · NA
Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program
- NCT06307652 · 4,800 participants · Phase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- NCT05252754 · 4,874 participants · Phase 3
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI